HIMSSCast

The Emergency Department is perhaps the singular environment in a hospital where the greatest concentration of decisions are made with the least amount of clinical data; and the acuity-level assigned at triage can massively impact the trajectory of care for apatient. Additionally, Emergency Departments in the United States have experiencedunprecedented levels of crowding over the last two decades, with correlation to worsened patient outcomes, preventable errors, and staff burnout.In 2017, the ED at Johns Hopkins deployed a CDS tool that leverages AI to generaterisk-driven triage acuity recommendations, instead of relying on resource-based ESI. The tool has provided more reliable detection of patients with critical illness and reduced the time patients wait for care. They’ve also seen marked decrease in those assigned to the mid-acuity level 3, and instead more utilization of the low-acuity levels 4 and 5, which lends to better fast-track throughput for those patients who are to be discharged.Jeremiah Hinson, MD PhD, will speak of his experience developing and utilizing the toolwith his team at Johns Hopkins.

Pharma & Healthtech partnerships have great potential. But delivering on thesepartnerships brings hurdles and challenges. From misaligned expectations to differences in culture and communication, it can be hard for the two worlds to find effective collaboration. Hear from Ameya Phadke, PhD. Patients Non-Pharma Solutions Leader at Chiesi Pharmaceuticals and Dennis Hermann, Head of Europe at Kaia Health discuss their partnership, as well as Dan Weinstein, Associate Principal at ZS Associates describe broader trends.

The mandate could have a detrimental effect on providers who can’t meet staffing levels, says Lee Hudson Teslik, founder and CEO of Reverence.

Clinical decision support is needed to handle the avalanche of data and to advance value-based care, says Yaw Fellin, VP of Products and Solutions for Wolters Kluwer Health’s Clinical Effectiveness team.

Prophecy International is an Australian based, publicly traded corporation thatstarted in the early ‘80’s. For over 40 years, Prophecy’s ever-evolving focuscontinues to bring reliable, secure, and trustworthy software solutions tomarkets across the globe. In the early 2000’s, Prophecy acquired its flagshipcyber security product, Snare, which was designed for the Australian military and defense. Snare’s suite of solutions continues to be a market leadingcentralized log management solution which is adopted by large enterpriseorganizations, military & defense, and government agencies through the world.

Drug+ care models allow patients to recover at home.

Moving forward on value-based care requires the collective weight of employers in these models, says APG President and CEO Susan Dentzer. 

Challenges and considerations for pharma and device companies.

While whole person care depends upon secure portability, there are three pathways to consider, according to Dr. Ben Zaniello, chief medical officer of PointClickCare.

Ferdinand Hamada and Matt DeFrain of MorganFranklin Consulting discuss the existing and evolving threat landscape – and give some tips on robust business continuity approaches.